
Episode 101: Colorectal Cancer Series, Pt. 3 - Adjuvant Therapy in Stage II Colon Cancer and ctDNA
The Fellow on Call: The Heme/Onc Podcast
00:00
Exploring Immunotherapy for Stage II and III Colon Cancer
This chapter explores the potential of immunotherapy as a treatment for MMR deficient and MSI high tumors in stage II and III colon cancer. It discusses recent findings from the NICHE2 trial and underscores the significance of shared decision-making in enhancing patient outcomes.
Transcript
Play full episode